Abstract:The brain develops and functions within a strictly controlled environment resulting from the coordinated action of different cellular interfaces located between the blood and the extracellular fluids of the brain, which include the interstitial fluid and the cerebrospinal fluid (CSF). As a correlate, the delivery of pharmacologically active molecules and especially macromolecules to the brain is challenged by the barrier properties of these interfaces. Blood-brain interfaces comprise both the blood-brain barrier located at the endothelium of the brain microvessels and the blood-CSF barrier located at the epithelium of the choroid plexuses. Although both barriers develop extensive surface areas of exchange between the blood and the neuropil or the CSF, the molecular fluxes across these interfaces are tightly regulated. Cerebral microvessels acquire a barrier phenotype early during cerebral vasculogenesis under the influence of the Wnt/β-catenin pathway, and of recruited pericytes. Later in development, astrocytes also play a role in blood-brain barrier maintenance. The tight choroid plexus epithelium develops very early during embryogenesis. It is specified by various signaling molecules from the embryonic dorsal midline, such as bone morphogenic proteins, and grows under the influence of Sonic hedgehog protein. Tight junctions at each barrier comprise a distinctive set of claudins from the pore-forming and tightening categories that determine their respective paracellular barrier characteristics. Vesicular traffic is limited in the cerebral endothelium and abundant in the choroidal epithelium, yet without evidence of active fluid phase transcytosis. Inorganic ion transport is highly regulated across the barriers. Small organic compounds such as nutrients, micronutrients and hormones are transported into the brain by specific solute carriers. Other bioactive metabolites, lipophilic toxic xenobiotics or pharmacological agents are restrained from accumulating in the brain by several ATP-binding cassette efflux transporters, multispecific solute carriers, and detoxifying enzymes. These various molecular effectors differently distribute between the two barriers. Receptor-mediated endocytotic and transcytotic mechanisms are active in the barriers. They enable brain penetration of selected polypeptides and proteins, or inversely macromolecule efflux as it is the case for immnoglobulins G. An additional mechanism specific to the BCSFB mediates the transport of selected plasma proteins from blood into CSF in the developing brain. All these mechanisms could be explored and manipulated to improve macromolecule delivery to the brain.

The Basic Requirement of Tight Junction Proteins in Blood-Brain Barrier Function and Their Role in Pathologies

Structure, Function, and Regulation of the Blood-Brain Barrier Tight Junction in Central Nervous System Disorders

Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation

Blood-brain barrier-morphology, modulation and clinical implications

Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection

Recapitulation of Structure–Function–Regulation of Blood–Brain Barrier under (Patho)Physiological Conditions

The Barrier and Interface Mechanisms of the Brain Barrier, and Brain Drug Delivery.

Blood brain barrier: A review of its anatomy and physiology in health and disease

The blood–brain barrier: structure, regulation, and drug delivery

Factors Influencing the Blood-Brain Barrier Permeability

Structure and function of the blood–brain barrier

Development of Novel Therapeutics Targeting the Blood–Brain Barrier: From Barrier to Carrier

Function of Connexins in the Interaction between Glial and Vascular Cells in the Central Nervous System and Related Neurological Diseases

Tight Junction Proteins Related to Blood-Brain Barrier and Their Regulatory Signaling Pathways in Ischemic Stroke.

The Role Of Ve-Cadherin In Blood-Brain Barrier Integrity Under Central Nervous System Pathological Conditions

Physiology of Blood–Brain Interfaces in Relation to Brain Disposition of Small Compounds and Macromolecules

Blood-Brain Barrier Disruption: A Common Driver of Central Nervous System Diseases

The penetration of therapeutics across the blood-brain barrier: Classic case studies and clinical implications

From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery

Establishment and Dysfunction of the Blood-Brain Barrier